🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find a safe, tolerable, and efficacious dos...
Status
Terminated
Location
Local Institution - 0047
Start Date
2023-11-09
Trial ID
NCT06024174
Treatments Being Tested
The objective of this study is to evaluate in a 3 +3 design, the safety of ...
Status
Completed
Location
University of California, Moores Cancer Center
Start Date
2015-12
Trial ID
NCT02643550
Treatments Being Tested
A first in human study to evaluate the safety and preliminary antitumor act...
Status
Recruiting
Location
The Angeles Clinic and Research Institute - West Los Angeles Office
Start Date
2025-03-31
Trial ID
NCT06917079
This is a multicenter, open-label study conducted in two phases: Phase 1 co...
Status
Unknown
Location
Memorial Care
Start Date
2016-02
Trial ID
NCT02675946
Treatments Being Tested
This is a phase 1/2, multi-center study with an open-label, dose escalation...
Status
Completed
Location
California Cancer Associates for Research and Excellence
Start Date
2020-09-03
Trial ID
NCT04474470
Treatments Being Tested
This is a three-part study of NUC-3373 administered by intravenous (IV) inf...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2018-10-05
Trial ID
NCT03428958
Phase 1 study to determine the safety and tolerability of QTX3046 as a sing...
Status
Active Not Recruiting
Location
South Texas Accelerated Research Therapeutics, LLC Midwest
Start Date
2024-05-30
Trial ID
NCT06428500
Phase 1 study to determine the safety, tolerability, and anti-tumor activit...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute
Start Date
2025-01-14
Trial ID
NCT06715124
This study is to evaluate the safety, tolerability, pharmacokinetics and an...
Status
Active Not Recruiting
Location
Research site31
Start Date
2022-02-17
Trial ID
NCT05194995
This Phase I clinical trial evaluates the safety, tolerability, and optimal...
Status
Recruiting
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2025-09-29
Trial ID
NCT06912087
Treatments Being Tested